U.S. Markets open in 5 hrs 9 mins
  • S&P Futures

    4,162.50
    +9.00 (+0.22%)
     
  • Dow Futures

    33,245.00
    +90.00 (+0.27%)
     
  • Nasdaq Futures

    14,075.25
    +40.25 (+0.29%)
     
  • Russell 2000 Futures

    2,237.80
    +7.20 (+0.32%)
     
  • Crude Oil

    71.93
    +0.29 (+0.40%)
     
  • Gold

    1,780.30
    +11.30 (+0.64%)
     
  • Silver

    26.08
    +0.11 (+0.43%)
     
  • EUR/USD

    1.1891
    +0.0025 (+0.2140%)
     
  • 10-Yr Bond

    1.4500
    0.0000 (0.00%)
     
  • Vix

    20.72
    +2.97 (+16.73%)
     
  • GBP/USD

    1.3835
    +0.0026 (+0.1909%)
     
  • USD/JPY

    110.0100
    -0.1400 (-0.1271%)
     
  • BTC-USD

    33,266.78
    -2,342.24 (-6.58%)
     
  • CMC Crypto 200

    821.66
    -118.29 (-12.58%)
     
  • FTSE 100

    7,006.76
    -10.71 (-0.15%)
     
  • Nikkei 225

    28,010.93
    -953.15 (-3.29%)
     

Accelerate Diagnostics: 1Q Earnings Snapshot

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

TUCSON, Ariz. (AP) _ Accelerate Diagnostics Inc. (AXDX) on Thursday reported a loss of $21.7 million in its first quarter.

The Tucson, Arizona-based company said it had a loss of 40 cents per share.

The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 43 cents per share.

The maker of systems that diagnose drug-resistant infections posted revenue of $1.8 million in the period, which missed Street forecasts. Three analysts surveyed by Zacks expected $2.1 million.

Accelerate Diagnostics shares have risen 72% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $19.77, a fall of 12% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AXDX at https://www.zacks.com/ap/AXDX